Kindred Biosciences, Inc.
KIN
KIN was delisted on the 27th of August, 2021.
57 hedge funds and large institutions have $81.5M invested in Kindred Biosciences, Inc. in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 14 closing their positions.
3% less capital invested
Capital invested by funds: $84.2M → $81.5M (-$2.74M)
5% less funds holding
Funds holding: 60 → 57 (-3)
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
24% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$6.59M |
| 2 |
New York State Common Retirement Fund
Albany,
New York
|
+$833K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$636K |
| 4 |
Goldman Sachs
New York
|
+$602K |
| 5 |
Renaissance Technologies
New York
|
+$448K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kingdon Capital Management
New York
|
-$2.49M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.84M |
| 3 |
JP Morgan Chase
New York
|
-$1.12M |
| 4 |
State Street
Boston,
Massachusetts
|
-$996K |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$660K |
KIN Hedge Fund Activity: Q2 2015 in Review
57 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q2 2015, worth a combined $81.5M — down 3.2% from $84.2M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of KIN and 12 opened new positions — a net loss of 2 holders — while 17 trimmed existing stakes and 13 added.
The largest buyer was Ariel Investments, adding an estimated $6.59M. The largest seller was Kingdon Capital Management, exiting entirely with an estimated $2.49M sold.
- 57 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q2 2015, down from 60 in Q1 2015.
- Funds reported $81.5M of Kindred Biosciences, Inc. stock for Q2 2015, down 3.2% quarter-over-quarter.
- 12 funds opened new Kindred Biosciences, Inc. positions in Q2 2015 and 14 closed out, a net change of -2 holders.
- The largest Kindred Biosciences, Inc. buyer in Q2 2015 was Ariel Investments, an estimated $6.59M added.
- The largest Kindred Biosciences, Inc. seller in Q2 2015 was Kingdon Capital Management, an estimated $2.49M sold.
Based on aggregated 13F filings for Q2 2015.